Younger Siblings, C-Reactive Protein, and Risk of Age-Related Macular Degeneration

Author： Cohn Amy C.   Busija Lucy   Robman Liubov D.   Dimitrov Peter N.   Varsamidis Mary   Lim Lyndell L.   Baird Paul N.   Guymer Robyn H.  

Publisher： Oxford University Press

ISSN： 1476-6256

Source： American Journal of Epidemiology, Vol.177, Iss.9, 2013-05, pp. : 933-943

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in the treatment of age-related macular degeneration

By Solebo Ameenat Lola   Angunawela Romesh I   Dasgupta Samipa   Marshall John  

British Journal of General Practice, Vol. 58, Iss. 550, 2008-05 ,pp. : 309-310

Royal College of General Practitioners

Access to resources Recommend Favorite

Age-related macular degeneration: an overview and update

By Lip PL   Menon VJK  

Therapy, Vol. 3, Iss. 3, 2006-05 ,pp. : 417-424

Future Medicine

Access to resources Recommend Favorite

Mechanisms of age‐related macular degeneration and therapeutic opportunities

By  

THE JOURNAL OF PATHOLOGY, Vol. 232, Iss. 2, 2014-01 ,pp. : 151-164

John Wiley & Sons Inc

Access to resources Recommend Favorite

Photobiomodulation in dry age‐related macular degeneration

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 1, 2018-02 ,pp. : e92-e92

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Statins and Angiotensin Converting Enzyme Inhibitors (ACE-Is) and the Risk of Age-Related Macular Degeneration: Nested Case-Control Study

By  

Current Drug Safety, Vol. 3, Iss. 1, 2008-01 ,pp. : 24-26

Bentham Science Publishers

Access to resources Recommend Favorite